Skip to main content
. 2019 Dec 23;11(12):e6453. doi: 10.7759/cureus.6453

Table 2. Primary Outcome .

CV: Cardiovascular

Primary Outcome Nebivolol (n=500) Bisoprolol (n=496) HR P-Value
All-cause mortality 49 (9.8%) 57 (11.49%) 0.77 (0.53 to 1.11) 0.16
CV mortality 27 (5.4%) 35 (7.0%) 0.76 (0.47 to 1.24) 0.28
All-cause hospitalization 72 (14.4%) 81 (16.3%) 0.88 (0.65 to 1.18)   0.39
CV hospitalization 49 (9.8%) 60 (12.09%) 0.80 (0.56 to 1.15) 0.23